Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting

The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)–Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Core Set working group is in the process of selecting core instruments for PsA clinical trials. During a 2-h workshop and breakout group discussions at the GRAPPA 2017 annual meeting in Amsterdam, the Netherlands, participants discussed the first set of candidate instruments to be taken through the OMERACT Filter 2.1 instrument selection process: 66/68 swollen/tender joint count (66/68JC), Spondyloarthritis Consortium of Canada (SPARCC) enthesitis index, patient’s global assessment (GRAPPA and OMERACT formulations), Health Assessment Questionnaire–Disability Index (HAQ-DI), Psoriatic Arthritis Impact of Disease (PsAID) questionnaires 9 and 12, and Functional Assessment of Chronic Illness Therapy (FACIT) Fatigue. Based on the assessment of domain match (content and face validity) and feasibility according to the OMERACT instrument selection criteria, the working group recommends continuing with appraisal of construct validity and discrimination for 66/68JC, SPARCC, PsAID 9 and 12, HAQ-DI, and FACIT-Fatigue. In addition, it recommends repeating the OMERACT Filter 2.1 process for patient global instruments because of insufficient votes. Additional sets of candidate instruments for the PsA core instrument set will be evaluated in a similar process.

[1]  B. Shea,et al.  Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016 , 2017, The Journal of Rheumatology.

[2]  M. D. de Wit,et al.  A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative. , 2017, Seminars in arthritis and rheumatism.

[3]  L. Coates,et al.  GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studies , 2017, Annals of the rheumatic diseases.

[4]  B. Shea,et al.  International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials , 2016, Annals of the rheumatic diseases.

[5]  M. D. de Wit,et al.  Enhanced Patient Involvement and the Need to Revise the Core Set — Report from the Psoriatic Arthritis Working Group at OMERACT 2014 , 2015, The Journal of Rheumatology.

[6]  P. Tugwell,et al.  Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. , 2014, Journal of clinical epidemiology.

[7]  M. D. de Wit,et al.  A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative , 2014, Annals of the rheumatic diseases.

[8]  I. Olivieri,et al.  Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study , 2011, The Journal of Rheumatology.

[9]  J. Sampalis,et al.  Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index , 2008, Annals of the rheumatic diseases.

[10]  A. Gottlieb,et al.  Consensus on a core set of domains for psoriatic arthritis. , 2007, The Journal of rheumatology.

[11]  Dafna Gladman,et al.  Classification criteria for psoriatic arthritis: development of new criteria from a large international study. , 2006, Arthritis and rheumatism.

[12]  D. Cella,et al.  Fatigue in cancer patients compared with fatigue in the general United States population , 2002, Cancer.

[13]  R. Francis,et al.  A comparison of the effectiveness and cost of treatment for vertebral fractures in women. , 1995, British journal of rheumatology.

[14]  J J Anderson,et al.  The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials , 1993 .

[15]  J. Fries,et al.  The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. , 1982, The Journal of rheumatology.

[16]  P. Tugwell,et al.  The OMERACT Handbook , 2014 .